Literature DB >> 15288922

The effect of a killed porcine reproductive and respiratory syndrome virus (PRRSV) vaccine treatment on virus shedding in previously PRRSV infected pigs.

D Nilubol1, K B Platt, P G Halbur, M Torremorell, D L Harris.   

Abstract

Two experiments were conducted to investigate if virus shedding could be reduced following a killed porcine reproductive and respiratory syndrome virus (PRRSV) vaccination (KV) of PRRSV infected pigs. In experiment 1, PRRSV infected pigs were vaccinated with KV on days 14 and 28 following infection. Viremia and serum neutralizing (SN) antibody were compared to infected pigs with no KV. The second experiment was conducted in an identical manner. In addition to viremia and SN antibody, virus in oropharyngeal scrapings and interferon gamma (IFN-gamma) producing cells were monitored. Magnitude and duration of viremia were not different between KV vaccinated and non-vaccinated groups. No virus was detected in oropharyngeal scraping from any pig, nor was there a difference in the detection of viral RNA. In both experiments, however, increases in SN titer and number of IFN-gamma producing cells were observed. The SN titer was significantly higher in KV vaccinated groups than in non-vaccinated group on days 42 and 42-56 following infection in experiments 1 and 2, respectively. The number of IFN-gamma producing cells was slightly higher in KV vaccinated groups than in non-vaccinated group on days 42 and 63. These observations suggest that KV had no effect on virus shedding. However, previously infected pigs responded immunologically to KV, as demonstrated by increases in SN antibody titers and IFN-gamma producing cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15288922     DOI: 10.1016/j.vetmic.2004.05.006

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  21 in total

1.  Suppression of porcine reproductive and respiratory syndrome virus replication in MARC-145 cells by shRNA targeting ORF1 region.

Authors:  Guanming Li; Juan Huang; Ping Jiang; Yufeng Li; Wenming Jiang; Xianwei Wang
Journal:  Virus Genes       Date:  2007-08-02       Impact factor: 2.332

2.  Immune responses in pigs induced by recombinant canine adenovirus 2 expressing the glycoprotein 5 of porcine reproductive and respiratory syndrome virus.

Authors:  J-X Zhou; J-D Xue; T Yu; J-B Zhang; Y Liu; N Jiang; Y-L Li; R-L Hu
Journal:  Vet Res Commun       Date:  2010-04-30       Impact factor: 2.459

3.  Efficacy of an inactivated PRRSV vaccine: induction of virus-neutralizing antibodies and partial virological protection upon challenge.

Authors:  Gerald Misinzo; Peter L Delputte; Peter Meerts; Christa Drexler; Hans J Nauwynck
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

4.  Protective humoral immune response induced by an inactivated porcine reproductive and respiratory syndrome virus expressing the hypo-glycosylated glycoprotein 5.

Authors:  Jung-Ah Lee; Byungjoon Kwon; Fernando A Osorio; Asit K Pattnaik; Nak-Hyung Lee; Sang-Won Lee; Seung-Yong Park; Chang-Seon Song; In-Soo Choi; Joong-Bok Lee
Journal:  Vaccine       Date:  2014-05-09       Impact factor: 3.641

5.  Antigen-specific B-cell responses to porcine reproductive and respiratory syndrome virus infection.

Authors:  Prasad Mulupuri; Jeffrey J Zimmerman; Joseph Hermann; Craig R Johnson; Jean Paul Cano; Wanqin Yu; Scott A Dee; Michael P Murtaugh
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

6.  The assessment of efficacy of porcine reproductive respiratory syndrome virus inactivated vaccine based on the viral quantity and inactivation methods.

Authors:  Hyunil Kim; Hye Kwon Kim; Jung Ho Jung; Yoo Jung Choi; Jiho Kim; Chang Gyu Um; Su Bin Hyun; Sungho Shin; Byeongchun Lee; Goo Jang; Bo Kyu Kang; Hyoung Joon Moon; Dae Sub Song
Journal:  Virol J       Date:  2011-06-27       Impact factor: 4.099

7.  Anti-idiotypic antibodies reduce efficacy of the attenuated vaccine against highly pathogenic PRRSV challenge.

Authors:  Ying Yu; Xuehui Cai; Gang Wang; Ning Kong; Yonggang Liu; Yihong Xiao; Chong Zhang; Yang Mu; Shuqi Xiao; Qin Zhao; Chengbao Wang; Gaiping Zhang; Julian A Hiscox; En-Min Zhou
Journal:  BMC Vet Res       Date:  2014-02-08       Impact factor: 2.741

8.  Comparison of host immune responses to homologous and heterologous type II porcine reproductive and respiratory syndrome virus (PRRSV) challenge in vaccinated and unvaccinated pigs.

Authors:  X Li; A Galliher-Beckley; L Pappan; B Trible; M Kerrigan; A Beck; R Hesse; F Blecha; J C Nietfeld; R R Rowland; J Shi
Journal:  Biomed Res Int       Date:  2014-02-26       Impact factor: 3.411

9.  The M/GP(5) glycoprotein complex of porcine reproductive and respiratory syndrome virus binds the sialoadhesin receptor in a sialic acid-dependent manner.

Authors:  Wander Van Breedam; Hanne Van Gorp; Jiquan Q Zhang; Paul R Crocker; Peter L Delputte; Hans J Nauwynck
Journal:  PLoS Pathog       Date:  2010-01-15       Impact factor: 6.823

10.  Comparison of the efficacy of autogenous inactivated Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) vaccines with that of commercial vaccines against homologous and heterologous challenges.

Authors:  Marc F Geldhof; Merijn Vanhee; Wander Van Breedam; Jan Van Doorsselaere; Uladzimir U Karniychuk; Hans J Nauwynck
Journal:  BMC Vet Res       Date:  2012-10-03       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.